Replimune Group, Inc. (REPL)

Replimune Group Market Cap

Replimune Group has a market cap or net worth of $461.53 million as of June 18, 2024. Its market cap has decreased by -64.45% in one year.

• Market Cap: 461.53M
• Enterprise Value: 129.47M
• 1-Year Change: -64.45%
• Ranking: #2974
• Category: Small-Cap
• Stock Price: $7.51

Market Cap Chart

Since July 20, 2018, Replimune Group's market cap has decreased from $467.50M to $461.53M, a decrease of -1.28%. That is a compound annual growth rate of -0.22%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2024	479.70M	-6.62%
Jun 14, 2024	513.70M	-11.58%
Jun 13, 2024	581.00M	7.25%
Jun 12, 2024	541.70M	-1.99%
Jun 11, 2024	552.70M	-
Jun 10, 2024	552.70M	13.91%
Jun 7, 2024	485.20M	11.11%
Jun 6, 2024	436.70M	27.88%
Jun 5, 2024	341.50M	9.67%
Jun 4, 2024	311.40M	-6.79%
Jun 3, 2024	334.10M	3.21%
May 31, 2024	323.70M	3.35%
May 30, 2024	313.20M	1.79%
May 29, 2024	307.70M	-3.27%
May 28, 2024	318.10M	-0.78%
May 24, 2024	320.60M	-7.77%
May 23, 2024	347.60M	-4.56%
May 22, 2024	364.20M	6.46%
May 21, 2024	342.10M	-6.22%
May 20, 2024	364.80M	-7.76%
May 17, 2024	395.50M	-4.17%
May 16, 2024	412.70M	-1.29%
May 15, 2024	418.10M	1.51%
May 14, 2024	411.90M	1.83%
May 13, 2024	404.50M	2.80%

View and export this data all the way back to 2018. Sign Up Today.

Related Stocks

Company	Market Cap
Celcuity	527.57M
Cross Country Healthcare	523.35M
Y-mAbs Therapeutics	522.64M
SI-BONE	521.65M
Cabaletta Bio	514.63M
MaxCyte	512.27M
Annexon	512.21M
Paragon 28	510.15M